TELA Bio’s $45.125 Million Common Stock Public Offering

Goodwin Procter advised TELA Bio, while Latham & Watkins advised the underwriters on the offering.TELA Bio, Inc. has announced the pricing of its previously announced underwritten public…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Pietro Martinoia

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here